Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Leyvraz

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Transplantation Proceedings|April 1, 1988
Altered activation pathways in T lymphocytes infiltrating human solid tumorsS Miescher, M Stoeck, T L Whiteside, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK)T Cerny, S Leyvraz, T von Briel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 17, 2008
Meaning in life assessed with the "Schedule for Meaning in Life Evaluation" (SMiLE): a comparison between a cancer patient and student sampleF Stiefel, S Krenz, C Zdrojewski, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 10, 2009
Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometryA Haouala, B Zanolari, B Rochat, et al.
Bone Marrow Transplantation|September 1, 1996
Sequential high-dose ICE chemotherapy with circulating progenitor cells (CPC) in small cell lung cancer: an EBMT studyL Perey, G Rosti, A Lange, et al.
Clinical and Experimental Immunology|October 20, 2005
Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapyM Montes, N Rufer, V Appay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative GroupJ A Wils, H O Klein, D J Wagener, et al.
British Journal of Cancer|October 13, 2006
Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapiesS Leyvraz, R Herrmann, L Guillou, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 4, 2005
The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylateG W Goerres, R Stupp, G Barghouth, et al.
Schweizerische Medizinische Wochenschrift|July 18, 1987
[Immunoscintigraphy using radio-labeled monoclonal antibodies. Development of a method of cancer diagnosis and hopes for a new form of therapy]J P Mach, A Bischof-Delaloye, S Curchod, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Transplantation Proceedings|April 1, 1988
Altered activation pathways in T lymphocytes infiltrating human solid tumorsS Miescher, M Stoeck, T L Whiteside, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK)T Cerny, S Leyvraz, T von Briel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 17, 2008
Meaning in life assessed with the "Schedule for Meaning in Life Evaluation" (SMiLE): a comparison between a cancer patient and student sampleF Stiefel, S Krenz, C Zdrojewski, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 10, 2009
Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometryA Haouala, B Zanolari, B Rochat, et al.
Bone Marrow Transplantation|September 1, 1996
Sequential high-dose ICE chemotherapy with circulating progenitor cells (CPC) in small cell lung cancer: an EBMT studyL Perey, G Rosti, A Lange, et al.
Clinical and Experimental Immunology|October 20, 2005
Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapyM Montes, N Rufer, V Appay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative GroupJ A Wils, H O Klein, D J Wagener, et al.
British Journal of Cancer|October 13, 2006
Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapiesS Leyvraz, R Herrmann, L Guillou, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 4, 2005
The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylateG W Goerres, R Stupp, G Barghouth, et al.
Schweizerische Medizinische Wochenschrift|July 18, 1987
[Immunoscintigraphy using radio-labeled monoclonal antibodies. Development of a method of cancer diagnosis and hopes for a new form of therapy]J P Mach, A Bischof-Delaloye, S Curchod, et al.
Pageof 11